HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IFF Continues Investing In Innovation With Creation Of Scientific Board

This article was originally published in The Rose Sheet

Executive Summary

The five experts who make up International Flavors & Fragrances’ newly created Scientific Advistory Board will help the company innovate to answer its customers’ needs and provide it with a “strong competitive advantage,” IFF says.

You may also be interested in...



Sales & Earnings In Brief

Product sales in China propel fourth-quarter revenue at Nu Skin Enterprises. International Flavors & Fragrances earnings over first three quarters offset a fourth-quarter slump. More financial news in brief.

Supplier IFF Promotes "Expert" Knowledge Of Developing Markets

Growth of the middle class in developing countries such as Brazil, Russia, India and China is driving demand for "better" fragrance products, and the shift bodes well for International Flavors & Fragrances, the firm's leadership suggests.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel